Cargando…
Master protocol trials in oncology: Review and new trial designs
In oncology, next generation sequencing and comprehensive genomic profiling have enabled the detailed classification of tumors using molecular biology. However, it is unrealistic to conduct phase I–III trials according to each sub-population based on patient molecular subtypes. Common protocols that...
Autores principales: | Hirakawa, Akihiro, Asano, Junichi, Sato, Hiroyuki, Teramukai, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120722/ https://www.ncbi.nlm.nih.gov/pubmed/30182068 http://dx.doi.org/10.1016/j.conctc.2018.08.009 |
Ejemplares similares
-
Practical basket design for binary outcomes with control of family-wise error rate
por: Asano, Junichi, et al.
Publicado: (2023) -
Master Protocol Trial Design for Efficient and Rational Evaluation of Novel Therapeutic Oncology Devices
por: Bitterman, Danielle S, et al.
Publicado: (2019) -
Corrigendum to: Master protocol trial design for efficient and rational evaluation of novel therapeutic oncology devices
Publicado: (2021) -
Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials
por: Di Liello, Raimondo, et al.
Publicado: (2021) -
Modern dose-finding designs for cancer phase I trials: drug combinations and molecularly targeted agents
por: Hirakawa, Akihiro, et al.
Publicado: (2018)